Minute Insight: SonALAsense MR-Guided Ultrasound Drug-Device Combo Trials Get Green Light
Executive Summary
SonALAsense has received Safe to Proceed letters from the FDA to begin trials of its ultrasound-activated cancer killing drug.
You may also be interested in...
Global Approvals Analysis: Eight Brain Device Approvals Mark Neurotech November
Medtech Insight's Approvals Tracker reports 22 medical device approvals from outside the United States in November, including 12 CE marks from Europe, plus approvals from Taiwan, Singapore, Japan, India, Canada, Australia and Argentina.
Leading The Way From A Singular Position - An IWD Perspective
Anne Osdoit has learned how to transform what would be challenges in her career into sources of inspiration. With this vital skill, she has not only led her company, Moon Surgical, to success, but also aided Sofinnova, where she serves as partner, in its investment strategy.
Sex-Based Diversity In Clinical Trials Can And Will Improve – An IWD Perspective
As a three-time cancer survivor and someone who has participated in a device trial, Alicia Staley, Medidata’s VP of patient engagement, is no stranger to innovative treatments. She spoke to Medtech Insight about how both the gender and socioeconomic diversity of trial participants could be improved.